Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1960 1
1962 3
1963 3
1965 2
1967 5
1970 2
1971 5
1972 1
1973 2
1974 5
1975 5
1976 8
1977 3
1978 9
1979 3
1980 3
1981 3
1982 3
1983 3
1984 1
1985 6
1986 4
1987 8
1988 2
1989 9
1990 9
1991 11
1992 13
1993 15
1994 13
1995 14
1996 10
1997 9
1998 7
1999 12
2000 12
2001 15
2002 8
2003 9
2004 12
2005 13
2006 10
2007 16
2008 15
2009 16
2010 19
2011 17
2012 18
2013 23
2014 17
2015 15
2016 9
2017 20
2018 23
2019 27
2020 21
2021 29
2022 37
2023 39
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Results by year

Filters applied: . Clear all
Page 1
TLR4 enhances TGF-beta signaling and hepatic fibrosis.
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. Seki E, et al. Among authors: osawa y. Nat Med. 2007 Nov;13(11):1324-32. doi: 10.1038/nm1663. Epub 2007 Oct 21. Nat Med. 2007. PMID: 17952090
Corrigenda.
Osawa Y, Seki T, Okura T, Takegami Y, Ishiguro N, Hasegawa Y. Osawa Y, et al. Bone Joint J. 2021 Sep;103-B(9):1551. doi: 10.1302/0301-620X.103B9.BJJ-2020-00019. Bone Joint J. 2021. PMID: 34465162 Free PMC article. No abstract available.
[THE PFAS].
Osawa Y. Osawa Y. Arerugi. 2023;72(1):18-21. doi: 10.15036/arerugi.72.18. Arerugi. 2023. PMID: 36792156 Japanese. No abstract available.
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T. Kawai H, et al. Among authors: osawa y. Hepatology. 2022 Jul;76(1):112-125. doi: 10.1002/hep.32256. Epub 2021 Dec 22. Hepatology. 2022. PMID: 34855990
Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Kimura M, Nishikawa K, Osawa Y, Imamura J, Yamaji K, Harada K, Yatsuhashi H, Murata K, Miura K, Tanaka A, Kanto T, Kohara M, Kamisawa T, Kimura K. Kimura M, et al. Among authors: osawa y. Hepatol Commun. 2022 Oct;6(10):2732-2747. doi: 10.1002/hep4.2043. Epub 2022 Jul 20. Hepatol Commun. 2022. PMID: 35855613 Free PMC article.
Liver disease secondary to congenital heart disease in children.
Komatsu H, Inui A, Kishiki K, Kawai H, Yoshio S, Osawa Y, Kanto T, Fujisawa T. Komatsu H, et al. Among authors: osawa y. Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):651-666. doi: 10.1080/17474124.2019.1621746. Epub 2019 May 26. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31131680 Review.
611 results